Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Pro Medicus Limited ( (AU:PME) ) just unveiled an update.
Pro Medicus Limited has announced that it will release its full year results for FY25 on August 14, 2025. The company will also hold a webcast conference call on the same day to discuss the results, indicating a transparent approach to stakeholder communication and potential implications for its market positioning.
The most recent analyst rating on (AU:PME) stock is a Hold with a A$130.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited is a leading company in the healthcare imaging industry, providing advanced imaging solutions and services. The company focuses on delivering innovative technology to enhance medical imaging processes and improve patient outcomes.
YTD Price Performance: 23.21%
Average Trading Volume: 231,748
Technical Sentiment Signal: Buy
Current Market Cap: A$32.16B
For a thorough assessment of PME stock, go to TipRanks’ Stock Analysis page.